Studies Point Way to Precision Therapies for Common Genetic Disorders

News   Feb 10, 2017 | Original story from Princeton University, Engineering School

 
Studies Point Way to Precision Therapies for Common Genetic Disorders

The researchers include: (from left) Trudi Schüpbach, the Henry Fairfield Osborn Professor of Biology; Rebecca Burdine, associate professor of molecular biology; Stanislav Shvartsman, Professor of Chemical and Biological Engineering and the Lewis Sigler Institute for Integrative Genomics; and Yogesh Goyal and Granton Jindal, graduate students in chemical and biological engineering.

 
 
 

RELATED ARTICLES

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

APC Protein Deletion Disrupts Cell Signalling and Could Cause Autism

News

Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.

READ MORE

How do Poison Frogs Protect Themselves Against Their Own Neurotoxin?

News

Scientists are a step closer to resolving a related head-scratcher, how do these frogs keep from poisoning themselves?

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE